thc and tirzepatide 📌 Editor's Choice from this week's issue of JAMA: ➡️ WHO Guideline on Use of #GLP-1s for #Obesity, ➡️ Review on Gastric #Cancer, ➡️ #Metformin Use in PAD, more. ja.ma/4eRp9GH Weight Loss Drugs: America's Latest

Results often begin within 4 to 8 weeks

Alongside medication, cognitive-behavioral therapy (CBT) is an effective non-pharmacological treatment option

The top ten factors for employers when considering GLP-1 coverage for weight loss are: Broker/consultant/PBM recommendations58% Obesity as a risk factor for chronic diseases and associated costs46% Impact/effectiveness of cost-control mechanisms on health insurance premiums44% Long-term costs and difficulty measuring outcomes41% Availability of direct-to-consumer options39% Oral pill forms available34% Selecting and monitoring vendor point solutions32% Medication adherence factors30% Immediate/short-term costs29% Expanded price transparency and flat-fee pricing26% Visit www.ifebp.org/GLP2026 for more information.

Reading the Numbers Honestly: The Full Comparison With the evidence caveats in place, the attribute-by-attribute comparison below summarizes the documented facts for each peptide

It lacks the essential amino acid leucine that triggers muscle protein synthesis

Among Medicare patients, 18% started with a GLP-1 while 24% used an SGLT2, reflecting the higher prevalence of cardiovascular conditions in seniors and the dual benefits SGLT2s provide in heart health